Skip to search.
 FTSE 100 Down 0.09%

More On UCBJY

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

UCB S.A. (UCBJY)

-Other OTC Ticker: 480101/ISIN: US9034801012
38.78 0.00(0.00%) 26 Feb 19:18
Add to Portfolio
Prev Close:38.78
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:38.78 - 38.78
52wk Range:36.78 - 49.29
Volume:25
Avg Vol (3m):816
Market Cap:15.09b
P/E (ttm):45.70
EPS (ttm):0.85
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for UCBJY at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

UCB S.A., a global biopharmaceutical company, focuses on central nervous system disorders and immunology diseases. The company’s core products include Cimzia for inflammatory arthritis indications and Crohn’s disease; Vimpat for epilepsy... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback